Gestational diabetes screening

Diabetes mellitus main page
Gestational diabetes Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Gestational Diabetes from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History and Prognosis
Complications Maternal Fetal and Neonatal
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Dietary Therapy
Medical Therapy
Primary Prevention
Secondary Prevention
Surgery
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Gestational diabetes screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Gestational diabetes screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Gestational diabetes screening
CDC on Gestational diabetes screening
Gestational diabetes screening in the news
Blogs on Gestational diabetes screening
Directions to Hospitals Treating Gestational diabetes
Risk calculators and risk factors for Gestational diabetes screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

2013 American Diabetes Association Standards of Medical Care in Diabetes (DO NOT EDIT)

Screening for Gestational Diabetes (GDM)

"1. Screen for undiagnosed type 2 diabetes at the first prenatal visit in those with risk factors, using standard diagnostic criteria. (Level of Evidence: B)"

"2. In pregnant women not previously known to have diabetes, screen for GDM at 24–28 weeks of gestation, using a 75-g 2-h OGTT. (Level of Evidence: B)"

"3. Screen womenwithGDMfor persistent diabetes at 6–12 weeks postpartum, using the OGTT and nonpregnancy diagnostic criteria. (Level of Evidence: E)"

"4. Women with a history of GDM should have lifelong screening for the development of diabetes or prediabetes at least every 3 years. (Level of Evidence: B)"

"4. Women with a history of GDM found to have prediabetes should receive lifestyle interventions or metformin to prevent diabetes. (Level of Evidence: A)"